Role of extracellular ATP and P2 receptor signaling in regulating renal cyst growth and interstitial inflammation in polycystic kidney disease

Frontiers in Physiology

Volumn 4 AUG, Issue , 2013, Pages

  Rangan, Gopi ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

ATP; Cyst; Interstitial inflammation; Polycystic kidney disease; Purinergic

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLORIDE; CHLORIDE CHANNEL; POLYCYSTIN; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CHRONIC INFLAMMATION; DISEASE COURSE; EPITHELIUM CELL; EXTRACELLULAR SPACE; HUMAN; HYPERTENSION; IN VITRO STUDY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY POLYCYSTIC DISEASE; NEPHRITIS; NONHUMAN; PARACRINE SIGNALING; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

EID: 84884563789     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00218     Document Type: Article

References (76)

1. Abbracchio, M. P., Burnstock, G., Verkhratsky, A., and Zimmermann, H. (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci. 32, 19-29. doi: 10.1016/j.tins.2008.10.001
2. Aguiari, G., Catizone, L., and Del Senno, L. (2013). Multidrug therapy for polycystic kidney disease: a review and perspective. Am. J. Nephrol. 37, 175-182. doi: 10.1159/000346812
3. Arulkumaran, N., Unwin, R. J., and Tam, F. W. (2011). A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 20, 897-915. doi: 10.1517/13543784.2011.578068
4. Baert, L. (1978). Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int. 13, 519-525. doi: 10.1038/ki.1978.75
5. Bailey, M. A., Hillman, K. A., and Unwin, R. J. (2000). P2 receptors in the kidney. J. Auton. Nerv. Syst. 81, 264-270. doi: 10.1016/S0165-1838(00)00125-9
6. Baxter, T. J. (1961). Observations on a polycystic kidney by microdissection. Aust. N.Z. J. Surg. 31, 115-125
7. Beis, I., and Newsholme, E. A. (1975). The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem. J. 152, 23-32
8. Belibi, F. A., Wallace, D. P., Yamaguchi, T., Christensen, M., Reif, G., and Grantham, J. J. (2002). The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 13, 2723-2729. doi: 10.1097/01.ASN.0000025282.48298.7B
9. Bergfeld, G. R., and Forrester, T. (1992). Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res. 26, 40-47. doi: 10.1093/cvr/26.1.40
10. Bhunia, A. K., Piontek, K., Boletta, A., Liu, L., Qian, F., Xu, P. N., et al. (2002). PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109, 157-168. doi: 10.1016/S0092-8674(02)00716-X
11. Bisceglia, M., Galliani, C. A., Senger, C., Stallone, C., and Sessa, A. (2006). Renal cystic diseases: a review. Adv. Anat. Pathol. 13, 26-56. doi: 10.1097/01.pap.0000201831.77472.d3
12. Boletta, A., and Germino, G. G. (2003). Role of polycystins in renal tubulogenesis. Trends Cell Biol. 13, 484-492. doi: 10.1016/S0962-8924(03)00169-7
13. Bowler, W. B., Buckley, K. A., Gartland, A., Hipskind, R. A., Bilbe, G., and Gallagher, J. A. (2001). Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone 28, 507-512. doi: 10.1016/S8756-3282(01)00430-6
14. Buchholz, B., Teschemacher, B., Schley, G., Schillers, H., and Eckardt, K. U. (2011). Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion. J. Mol. Med. (Berl.) 89, 251-261. doi: 10.1007/s00109-010-0715-1
15. Chang, M. Y., Lu, J. K., Tian, Y. C., Chen, Y. C., Hung, C. C., Huang, Y. H., et al. (2011). Inhibition of the P2X7 receptor reduces cystogenesis in PKD. J. Am. Soc. Nephrol. 22, 1696-1706. doi: 10.1681/ASN.2010070728
16. Chang, M. Y., and Ong, A. C. (2013). New treatments for autosomal dominant polycystic kidney disease. Br. J. Clin. Pharmacol. doi: 10.1111/bcp.12136. [Epub ahead of print]
17. Cowley, B. D. Jr. (2008). Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease. Kidney Int. 73, 251-253. doi: 10.1038/sj.ki.5002695
18. Crikis, S., Lu, B., Murray-Segal, L. M., Selan, C., Robson, S. C., D'Apice, A. J., et al. (2010). Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am. J. Transplant. 10, 2586-2595. doi: 10.1111/j.1600-6143.2010.03257.x
19. Deplano, S., Cook, H. T., Russell, R., Franchi, L., Schneiter, S., Bhangal, G., et al. (2013). P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis. J. Leukoc. Biol. 93, 127-134. doi: 10.1189/jlb.0612284
20. Di Virgilio, F. (2012). Purines, purinergic receptors, and cancer. Cancer Res. 72, 5441-5447. doi: 10.1158/0008-5472.CAN-12-1600
21. Eltzschig, H. K., Rivera-Nieves, J., and Colgan, S. P. (2009). Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin. Ther. Targets 13, 1267-1277. doi: 10.1517/14728220903241666
22. Fedeles, S. V., Tian, X., Gallagher, A. R., Mitobe, M., Nishio, S., Lee, S. H., et al. (2011). A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat. Gen. 43, 639-647. doi: 10.1038/ng.860
23. Ferguson, D. R., Kennedy, I., and Burton, T. J. (1997). ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J. Physiol. 505(Pt 2), 503-511. doi: 10.1111/j.1469-7793.1997.503bb.x
24. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., et al. (2009). Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15, 1170-1178. doi: 10.1038/nm.2028
25. Goilav, B. (2011). Apoptosis in polycystic kidney disease. Biochim. Biophys. Acta 1812, 1272-1280. doi: 10.1016/j.bbadis.2011.01.006
26. Goncalves, R. G., Gabrich, L., Rosario, A. Jr., Takiya, C. M., Ferreira, M. L., Chiarini, L. B., et al. (2006). The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int. 70, 1599-1606. doi: 10.1038/sj.ki.5001804
27. Gorman, M. W., Feigl, E. O., and Buffington, C. W. (2007). Human plasma ATP concentration. Clin. Chem. 53, 318-325. doi: 10.1373/clinchem.2006.076364
28. Grantham, J. J., Mulamalla, S., and Swenson-Fields, K. I. (2011). Why kidneys fail in autosomal dominant polycystic kidney disease. Nat. Rev. Nephrol. 7, 556-566. doi: 10.1038/nrneph.2011.109
29. Grantham, J. J., Uchic, M., Cragoe, E. J. Jr., Kornhaus, J., Grantham, J. A., Donoso, V., et al. (1989). Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int. 35, 1379-1389. doi: 10.1038/ki.1989.137
30. Harris, P. C., and Torres, V. E. (2009). Polycystic kidney disease. Annu. Rev. Med. 60, 321-337. doi: 10.1146/annurev.med.60.101707.125712
31. Hildebrandt, F., and Otto, E. (2005). Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat. Rev. Gen. 6, 928-940. doi: 10.1038/nrg1727
32. Hillman, K. A., Burnstock, G., and Unwin, R. J. (2005). The P2X7 ATP receptor in the kidney: a matter of life or death? Nephron 101, e24-e30
33. Hillman, K. A., Johnson, T. M., Winyard, P. J., Burnstock, G., Unwin, R. J., and Woolf, A. S. (2002). P2X(7) receptors are expressed during mouse nephrogenesis and in collecting duct cysts of the cpk/cpk mouse. Exp. Nephrol. 10, 34-42. doi: 10.1159/000049896
34. Hillman, K. A., Woolf, A. S., Johnson, T. M., Wade, A., Unwin, R. J., and Winyard, P. J. (2004). The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem. Biophys. Res. Commun. 322, 434-439. doi: 10.1016/j.bbrc.2004.07.148
35. Hooper, K. M., Unwin, R. J., and Sutters, M. (2003). The isolated C-terminus of polycystin-1 promotes increased ATP-stimulated chloride secretion in a collecting duct cell line. Clin. Sci. (Lond.) 104, 217-221. doi: 10.1042/CS20020239
36. Hovater, M. B., Olteanu, D., Hanson, E. L., Cheng, N. L., Siroky, B., Fintha, A., et al. (2008). Loss of apical monocilia on collecting duct principal cells impairs ATP secretion across the apical cell surface and ATP-dependent and flow-induced calcium signals. Purinergic Signal. 4, 155-170. doi: 10.1007/s11302-007-9072-0
37. Hovater, M. B., Olteanu, D., Welty, E. A., and Schwiebert, E. M. (2008). Purinergic signaling in the lumen of a normal nephron and in remodeled PKD encapsulated cysts. Purinergic Signal. 4, 109-124. doi: 10.1007/s11302-008-9102-6
38. Hu, J., and Barr, M. M. (2005). ATP-2 interacts with the PLAT domain of LOV-1 and is involved in Caenorhabditis elegans polycystin signaling. Mol. Biol. Cell 16, 458-469. doi: 10.1091/mbc.E04-09-0851
39. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Willart, M. A., Muskens, F., et al. (2007). Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13, 913-919. doi: 10.1038/nm1617
40. Ishikawa, S., Higashiyama, M., Kusaka, I., Saito, T., Nagasaka, S., and Fukuda, S. (1997). Extracellular ATP promotes cellular growth of renal inner medullary collecting duct cells mediated via P2u receptors. Nephron 76, 208-214. doi: 10.1159/000190170
41. Ivison, S. M., Himmel, M. E., Mayer, M., Yao, Y., Kifayet, A., Levings, M. K., et al. (2011). The stress signal extracellular ATP modulates antiflagellin immune responses in intestinal epithelial cells. Inflamm. Bowel Dis. 17, 319-333. doi: 10.1002/ibd.21428
42. Jacobson, K. A., and Boeynaems, J. M. (2010). P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov. Today 15, 570-578. doi: 10.1016/j.drudis.2010.05.011
43. Kaimori, J. Y., and Germino, G. G. (2008). ARPKD and ADPKD: first cousins or more distant relatives? J. Am. Soc. Nephrol. 19, 416-418. doi: 10.1681/ASN.2008010033
44. Katsuragi, T., Sato, C., Usune, S., Ueno, S., Segawa, M., and Migita, K. (2008). Caffeine-inducible ATP release is mediated by Ca2+-signal transducing system from the endoplasmic reticulum to mitochondria. Naunyn Schmiedebergs Arch. Pharmacol. 378, 93-101. doi: 10.1007/s00210-008-0292-9
45. Kelsey, R. (2013). Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results. Nat. Rev. Nephrol. 9, 1. doi: 10.1038/nrneph.2012.236
46. Kishore, B. K., Chou, C. L., and Knepper, M. A. (1995). Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am. J. Physiol. 269(6 Pt 2), F863-F869
47. Kishore, B. K., Ginns, S. M., Krane, C. M., Nielsen, S., and Knepper, M. A. (2000). Cellular localization of P2Y(2) purinoceptor in rat renal inner medulla and lung. Am. J. Phsyiol. 278, F43-F51
48. Lazarowski, E. R., Rochelle, L. G., O'Neal, W. K., Ribeiro, C. M., Grubb, B. R., Zhang, V., et al. (2001). Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder. J. Pharmacol. Exp. Therap. 297, 43-49
49. Leipziger, J. (2003). Control of epithelial transport via luminal P2 receptors. Am. J. Physiol. 284, F419-F432
50. Leite, M. A., Monteiro Pereira, J., Barreira, A., Gomes, C. R., and Takiya, C. M. (2012). Brilliant Blue G, a P2X7 antagonist, atteunates renal inflammation and fibrosis in unilateral uretral obstruction in rats (abstract). J. Am. Soc. Nephrol. 23, 325A
51. Lohman, A. W., Billaud, M., and Isakson, B. E. (2012). Mechanisms of ATP release and signalling in the blood vessel wall. Cardiovasc. Res. 95, 269-280. doi: 10.1093/cvr/cvs187
52. Luft, F. C. (2011). The Gretchen question in autosomal-dominant polycystic kidney disease research. J. Mol. Med. (Berl.) 89, 247-250. doi: 10.1007/s00109-011-0734-6
53. Martinez, J. R., and Grantham, J. J. (1995). Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis. Mon. 41, 693-765. doi: 10.1016/S0011-5029(05)80007-0
54. Nauli, S. M., Rossetti, S., Kolb, R. J., Alenghat, F. J., Consugar, M. B., Harris, P. C., et al. (2006). Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J. Am. Soc. Nephrol. 17, 1015-1025. doi: 10.1681/ASN.2005080830
55. Rangan, G. K., Shtangey, V., and McDonald, S. P. (2005). Characteristics and survival of endstage renal failure patients with polycystic kidney disease. Nephrology 10, A403
56. Rossetti, S., Kubly, V. J., Consugar, M. B., Hopp, K., Roy, S., Horsley, S. W., et al. (2009). Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 75, 848-855. doi: 10.1038/ki.2008.686
57. Savi, P., and Herbert, J. M. (2005). Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin. Thromb. Hemost. 31, 174-183. doi: 10.1055/s-2005-869523
58. Schwiebert, E. M. (2001). ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clin. Exp. Pharmacol. Physiol. 28, 340-350. doi: 10.1046/j.1440-1681.2001.03451.x
59. Schwiebert, E. M., Wallace, D. P., Braunstein, G. M., King, S. R., Peti-Peterdi, J., Hanaoka, K., et al. (2002). Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am. J. Physiol. 282, F763-F775
60. Sullivan, L. P., Wallace, D. P., and Grantham, J. J. (1998). Epithelial transport in polycystic kidney disease. Physiol. Rev. 78, 1165-1191
61. Sweeney, W. E. Jr., and Avner, E. D. (2006). Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res. 326, 671-685. doi: 10.1007/s00441-006-0226-0
62. Swenson-Fields, K. I., Vivian, C. J., Salah, S. M., Peda, J. D., Davis, B. M., van Rooijen, N., et al. (2013). Macrophages promote polycystic kidney disease progression. Kidney Int. 83, 855-864. doi: 10.1038/ki.2012.446
63. Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., et al. (2002). Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002
64. Ta, M. H., Harris, D., and Rangan, G. K. (2013). Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology 18, 317-330. doi: 10.1111/nep.12045
65. Taylor, S. R., Turner, C. M., Elliott, J. I., McDaid, J., Hewitt, R., Smith, J., et al. (2009). P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 1275-1281. doi: 10.1681/ASN.2008060559
66. Terryn, S., Ho, A., Beauwens, R., and Devuyst, O. (2011). Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease. Biochim. Biophys. Acta 1812, 1314-1321. doi: 10.1016/j.bbadis.2011.01.011
67. Torres, V. E., Harris, P. C., and Pirson, Y. (2007). Autosomal dominant polycystic kidney disease. Lancet 369, 1287-1301. doi: 10.1016/S0140-6736(07)60601-1
68. Turner, C. M., King, B. F., Srai, K. S., and Unwin, R. J. (2007). Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am. J. Physiol. 292, F15-F25
69. Turner, C. M., Ramesh, B., Srai, S. K., Burnstock, G., and Unwin, R. J. (2004). Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease. Cells Tissues Organs 178, 168-179. doi: 10.1159/000082247
70. Wang, X., Gattone, V. 2nd., Harris, P. C., and Torres, V. E. (2005). Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J. Am. Soc. Nephrol. 16, 846-851. doi: 10.1681/ASN.2004121090
71. Wildman, S. S., Hooper, K. M., Turner, C. M., Sham, J. S., Lakatta, E. G., King, B. F., et al. (2003). The isolated polycystin-1 cytoplasmic COOH terminus prolongs ATP-stimulated Cl- conductance through increased Ca2+ entry. Am. J. Physiol. 285, F1168-F1178
72. Wilson, P. D. (1997). Epithelial cell polarity and disease. Am. J. Physiol. 272(4 Pt 2), F434-F442
73. Wilson, P. D., Hovater, J. S., Casey, C. C., Fortenberry, J. A., and Schwiebert, E. M. (1999). ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J. Am. Soc. Nephrol. 10, 218-229
74. Witzgall, R., Kranzlin, B., Gretz, N., and Obermuller, N. (2002). Impaired endocytosis may represent an obstacle to gene therapy in polycystic kidney disease. Kidney Int. 61(Suppl. 1), S132-S137. doi: 10.1046/j.1523-1755.2002.0610s1132.x
75. Wolf, M. T., and Hildebrandt, F. (2011). Nephronophthisis. Pediatr. Nephrol. 26, 181-194. doi: 10.1007/s00467-010-1585-z
76. Xu, C., Shmukler, B. E., Nishimura, K., Kaczmarek, E., Rossetti, S., Harris, P. C., et al. (2009). Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. Am. J. Physiol. 296, F1464-F1476